The Kromek Group plc is listed on London’s Alternative Investment Market, AIM. Its ordinary shares carry the symbol KMK-L. Kromek Group plc is incorporated in England and Wales under the Companies Act 2006 (registration number 8661469). With facilities in the UK and US, Kromek sells internationally with partnerships and distribution channels in Asia, Europe, and North America, to a global customer base.
This section was last updated on 19 March 2019.
18/03/2019 Director Dealings Correction.
28/02/2019 TR-1 Canaccord Genuity
28/02/2019 TR-1 Killik & Co
28/02/2019 TR-1 Miton Diverse Income Trust
28/02/2019 TR-1 Miton Group
28/02/2019 TR-1 Miton UK Microcap Trust
26/02/2019 Directors Dealings 26.02.19.
26/02/2019 Kromek contract with new OEM for nuclear security.
25/02/2019 Results of General Meeting and Open Offer and Total Voting Rights
07/02/2019 Firm Placing and Open Offer to raise up to £21 million and Notice of General Meeting.
31/01/2019 Total Voting Rights
28/01/2019 Kromek awarded $58M medical imaging contract.
14/01/2019 Kromek Interim Results 2018-19
18/12/2018 Notice of half-year results.
10/12/2018 Kromek awarded first biological-threat detection contract by the US Department of Defense.
19/11/2018 Kromek secures five-year $7.8m baggage screening contract.
01/10/2018 Results of Kromek AGM Oct 2018
27/09/2018 Kromek awarded $1.8m funding from US Defense Threat Reduction.
07/09/2018 Notice of AGM and Posting of Annual Report.
20/08/2018 Kromek wins two new contracts in the medical division.
23/07/2018 Kromek secures two contracts worth up to $3.3 million from US government
02/07/2018 Final Results for the Year ended 30 April 2018
30/05/2018 Kromek secures five-year medical contract
01/05/2018 Trading Update
23/04/18 Kromek awarded three-year project by Innovate UK to deliver Molecular Breast Imaging Device
12/01/18 Kromek awarded $1.6m extension to contract with DARPA
11/01/18 Appointment of Joint Broker